Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Qiangnu Zhang, Weibin Hu, Lingfeng Xiong, Teng Wei, Lesen Yan, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Gongze Peng, Shiyun Bao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Goals and targets for personalized therapy for HCC
10.1007/s12072-018-9919-1 · 2019
10.1053/j.gastro.2023.01.033
10.1053/j.gastro.2023.01.033
Research progress and prospects of circulating tumor cells in hepatocellular carcinoma
10.1016/j.hbpd.2022.07.001 · 2022
10.3322/caac.21660
10.3322/caac.21660
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
10.1186/s13046-021-01968-w · 2021
10.1038/s12276-020-00527-1
10.1038/s12276-020-00527-1
Management of adverse events associated with tyrosine kinase inhibitors: improving outcomes for patients with hepatocellular carcinoma
10.1016/j.ctrv.2019.05.004 · 2019
Emerging biomarkers in HCC patients: current status
10.1016/j.ijsu.2020.04.043 · 2020
Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis
10.3748/wjg.v25.i30.4199 · 2019
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma
2023
Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma
2023
ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC
2021
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8
10.1074/mcp.tir119.001673
10.1074/mcp.tir119.001673
10.1093/nar/gkx247
10.1093/nar/gkx247
10.1016/j.gpb.2018.07.003
10.1016/j.gpb.2018.07.003
CancerLivER: a database of liver cancer gene expression resources and biomarkers
2020
Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the SLC25A15 gene
10.3389/fgene.2022.1004598 · 2022
10.1016/j.cell.2018.07.019
10.1016/j.cell.2018.07.019
10.1002/hep.32088
10.1002/hep.32088
10.1016/j.celrep.2022.110697
10.1016/j.celrep.2022.110697
10.1016/j.jhep.2021.08.011
10.1016/j.jhep.2021.08.011
A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma
10.1111/jcmm.16249 · 2021
Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma
10.18632/aging.202723 · 2021
Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume II
10.3389/fgene.2022.959159 · 2022
Recent trends in cancer genomics and bioinformatics tools development
10.3390/ijms222212146 · 2021
A review of bioinformatics tools and web servers in different microarray platforms used in cancer research
10.1016/bs.apcsb.2022.05.002 · 2022
Bioinformatics tools and resources for cancer immunotherapy study
10.1007/978-1-4939-9773-2_29 · 2020
10.1038/s41575-019-0145-7
10.1038/s41575-019-0145-7
10.1038/s41575-020-00381-6
10.1038/s41575-020-00381-6
Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and c infections: a review
10.3390/ijms20061358 · 2019
10.1016/j.cell.2017.05.046
10.1016/j.cell.2017.05.046
10.1016/j.hbpd.2020.05.002
10.1016/j.hbpd.2020.05.002
A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients
10.7717/peerj.12572 · 2021
Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma
10.1186/s12859-023-05391-0 · 2023
Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma
2023
No additional external references are available.